Literature DB >> 4125265

Australia antigen: persistence of immunological markers (d, y, w) in antigen carriers.

S Mazzur, B S Blumberg.   

Abstract

It is important to establish the stability of Australia antigen subtypes in chronic carriers in order to evaluate the validity of using immunological determinants as long-term epidemiological markers. In this study sequential blood samples containing Australia antigen from 31 chronic carriers were typed for determinants d, y, and w. The subjects included asymptomatic carriers from Rongelap Atoll in the Marshall Islands, Down's syndrome patients, and renal patients receiving hemodialysis treatment. The period of time between blood samples extended from 3 months to 11 years. In no case did the subtype change within any individual. It appears from these data that the Australia antigen subtypes are good long-term markers for epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4125265      PMCID: PMC422830          DOI: 10.1128/iai.8.2.178-181.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Additional specificities of Australia antigen and the possible identification of hepatitis carriers.

Authors:  C Levene; B S Blumberg
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

2.  Subtypes of Australia antigen and hepatitis-B virus.

Authors:  G L Le Bouvier; R W McCollum; W J Hierholzer; G R Irwin; S Krugman; J P Giles
Journal:  JAMA       Date:  1972-11-20       Impact factor: 56.272

3.  Immunologic and electrophoretic heterogeneity of hepatitis-associated antigen.

Authors:  C Y Kim; J G Tilles
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

4.  Viral hepatitis. Revised concepts as a result of the study of Australia antigen.

Authors:  A I Sutnick; W T London; I Millman; V E Coyne; B S Blumberg
Journal:  Med Clin North Am       Date:  1970-05       Impact factor: 5.456

Review 5.  Australia antigen as a hepatitis virus. Variation in host response.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Am J Med       Date:  1970-01       Impact factor: 4.965

6.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

Authors:  W T London; M Di Figlia; A Sutnick; B S Blumberg
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

7.  Family studies of a human serum isoantigen system (Australia antigen).

Authors:  B S Blumberg; L Melartin; R A Guint; B Werner
Journal:  Am J Hum Genet       Date:  1966-11       Impact factor: 11.025

8.  Specificities of human antibodies to Australia antigen.

Authors:  V K Raunio; W T London; A I Sutnick; I Millman; B S Blumberg
Journal:  Proc Soc Exp Biol Med       Date:  1970-06

9.  Australia antigen and hepatitis. Studies in asymptomatic people and lepromatous leprosy patient.

Authors:  B S Blumberg; L Melartin
Journal:  Arch Intern Med       Date:  1970-02

10.  Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans.

Authors:  B S Blumberg; J S Friedlaender; A Woodside; A I Sutnick; W T London
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

View more
  1 in total

1.  Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.

Authors:  E Perry; R K Chaudhary; T E Cleary; F R Roughley
Journal:  Can Med Assoc J       Date:  1975-01-11       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.